Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

194 projects found matching your search criteria :

  1. MIST: Artificial intelligence-assisted design of experiments as a tool to streamline the development of siRNA-lipid nano...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr hab. Paulina Krystyna Skupin-Mrugalska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  2. Destabilization of neuronal morphology in chronic inflammation: molecular mechanisms and identification of potential the...

    Call: OPUS 29 , Panel: NZ5

    Principal investigator: prof. Jacek Ryszard Jaworski

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

  3. Developing an AI algorithm for longitudinal tracking of post-treatment changes in brain metastases using a hybrid Uncert...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Monika Żaneta Pytlarz

    Sano - Centrum Zindywidualizowanej Medycyny Obliczeniowej - Międzynarodowa Fundacja Badawcza

  4. Astrocytic Mitochondria in PACS2 Syndrome: Pathogenesis and Therapeutic Intervention

    Call: PRELUDIUM 24 , Panel: NZ5

    Principal investigator: Arkadiusz Franciszek Żbikowski

    Uniwersytet Medyczny w Białymstoku

  5. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Weronika Wojtyś

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  6. The JAK/STAT pathway as a molecular contributor to the development of endometriosis: therapeutic potential of JAK inhibi...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Aleksander Radosław Rycerz

    Uniwersytet Medyczny w Łodzi

  7. CTC-on-CAM: a platform for studying heterogeneity, epithelial-mesenchymal transition, and therapeutic sensitivity of cir...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  8. Molecular Pathogenesis and Precision Antisense Oligonucleotide Therapy for BAG3-Related Myofibrillar Myopathy Type 6 Usi...

    Call: OPUS 29 , Panel: NZ2

    Principal investigator: dr Estera Elmira Rintz

    Uniwersytet Gdański

  9. Therapeutic evaluation of anti-fibrotic agents for thyroid eye disease (TED) in a preclinical mouse model

    Call: PRELUDIUM 24 , Panel: NZ6

    Principal investigator: Paweł Franciszek Tyrna

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  10. Therapeutic potential of an FGF21 analogue in HFpEF: targeting cardiac, skeletal muscle, and cognitive function to impro...

    Call: PRELUDIUM 24 , Panel: NZ4

    Principal investigator: Maria Katarzyna Głowienka-Stodolak

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  11. Targeted Degradation of the MLL Complex in Leukemia: A PROTAC-Based Therapeutic Strategy

    Call: SONATINA 9 , Panel: ST5

    Principal investigator: dr Natalia Anna Skrzypczak

    Fundacja Uniwersytetu im. Adama Mickiewicza

  12. Antibacterial molecules based on bacteriophage proteins and constant antibody fragments with therapeutic potential for t...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Karolina Aleksandra Filik-Matyjaszczyk

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  13. Modulating Neuroplasticity with Psilocybin: Assesment Therapeutic Potential in Treating Fentanyl use disorder

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Ewa Taracha

    Instytut Psychiatrii i Neurologii

  14. Identifying early biomarkers and molecular targets for therapeutic intervention in right ventricular dysfunction

    Call: OPUS 28 , Panel: NZ5

    Principal investigator: prof. Przemysław Błyszczuk

    Uniwersytet Jagielloński

  15. Porous bioglass-alginate composite granules as the antibiotic delivery system with therapeutic and regenerative potentia...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Adrian Szewczyk

    Gdański Uniwersytet Medyczny

  16. A triple agonist of glucagon, GLP-1, and GIP receptors as a novel therapeutic option for the treatment of heart failure ...

    Call: SONATA 20 , Panel: NZ5

    Principal investigator: dr Marta Katarzyna Oknińska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  17. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

  18. The H3K27M oncohistone-centred molecular mechanisms as therapeutic targets in pediatric malignant diffuse midline glioma...

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Katarzyna Leszczyńska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  19. Exploring DMRTA2 in Glioblastoma: Epigenetic Regulation, Angiogenesis Disruption, and Biomarker Development

    Call: SONATA BIS 14 , Panel: NZ3

    Principal investigator: dr Marta Magdalena Maleszewska-Bobińska

    Uniwersytet Warszawski

  20. Improving the therapeutic potential of cytostatics through the use of abiotic metallacarboranes.

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Michalina Gos

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  21. Development of novel potential therapeutics in inflammatory bowel diseases based on nanoformulations employing senomodul...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Jakub Jerzy Fichna

    Uniwersytet Medyczny w Łodzi

  22. CD147 as a novel multifunctional modulator of podocyte metabolism and exosome biogenesis: Identification of new molecula...

    Call: OPUS 27 , Panel: NZ4

    Principal investigator: dr hab. Agnieszka Piwkowska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  23. ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease

    Call: M-ERA.NET 3 Call 2023 , Panel: NZ5

    Principal investigator: dr hab. Anna Ludwika Haduch

    Instytut Farmakologii PAN

  24. Is there an escape from antibioticresistant ESKAPE pathogens present in wastewater - the importance of last-chance antib...

    Call: SONATA 19 , Panel: NZ9

    Principal investigator: dr Katarzyna Natalia Grudlewska-Buda

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

  25. Modulation of protein interaction networks as a new therapeutic target in the treatment of hereditary retinal dystrophie...

    Call: SONATA 19 , Panel: NZ5

    Principal investigator: dr Xiaonan Liu

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

  26. Evaluation of the therapeutic potential of synthetic miRNA-223-3p analog in a rat model of severe asthma

    Call: SONATA 19 , Panel: NZ4

    Principal investigator: dr Wojciech Jerzy Langwiński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  27. Actin cytoskeleton disorders as a pro-survival signaling activator and a therapeutic biomarker in Diffuse Large B-cell L...

    Call: SONATA BIS 13 , Panel: NZ5

    Principal investigator: dr Patryk Górniak

    Instytut Hematologii i Transfuzjologii

  28. Targeting IGH enhancer RNAs as a therapeutic approach in B-cell lymphoma

    Call: SONATA BIS 13 , Panel: NZ1

    Principal investigator: dr hab. Agnieszka Dzikiewicz-Krawczyk

    Instytut Genetyki Człowieka PAN

  29. Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

    Call: SONATA BIS 13 , Panel: NZ7

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

  30. Exploring the Therapeutic Effects of Human Adipose Tissue Mesenchymal Stem Cell (HATMSC) line Secretome on Chronic Skin ...

    Call: SONATA BIS 13 , Panel: NZ3

    Principal investigator: dr Honorata Kraśkiewicz

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  31. The inhibition of NMDAR and TRPM4 coupling - a hope for novel therapeutic target for the treatment of the ischemic brain...

    Call: SONATA BIS 13 , Panel: NZ7

    Principal investigator: dr Bartosz Sebastian Pomierny

    Uniwersytet Jagielloński, Collegium Medicum

  32. Three to tango - biomaterials with therapeutic and regenerative multifunctionality

    Call: SONATA BIS 13 , Panel: ST11

    Principal investigator: dr Marzena Krystyna Fandzloch

    Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

  33. Prioritizing diagnostics and therapeutics of human prion diseases through integrative omics

    Call: JPND Call 2023 , Panel: NZ2

    Principal investigator: prof. Beata Katarzyna Sikorska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  34. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden...

    Call: PRELUDIUM 22 , Panel: NZ5

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

  35. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res...

    Call: OPUS 25 , Panel: NZ5

    Principal investigator: dr hab. Mariusz Łukasz Hartman

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  36. Bigels with controlled release of hydrophilic and hydrophobic therapeutic compounds as potential dressings in the treatm...

    Call: OPUS 25 , Panel: ST11

    Principal investigator: dr hab. Monika Gosecka

    Centrum Badań Molekularnych i Makromolekularnych PAN

  37. Designing Active Inhibitors of SARS-CoV-2 Methyltransferases

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Alex Jun Matsuda

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  38. Targeting undruggable proteins involved in tumorigenesis – developing and characterization of advanced nanoplatform for ...

    Call: OPUS 25 , Panel: NZ6

    Principal investigator: dr hab. Monika Bzowska

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Bitechnologii

  39. Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b...

    Call: PRELUDIUM 22 , Panel: NZ7

    Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

    Instytut Farmakologii PAN

  40. Therapeutic self-understanding

    Call: SONATA 18 , Panel: HS1

    Principal investigator: dr Jędrzej Piotr Grodniewicz

    Uniwersytet Jagielloński, Centrum Kopernika Badań Interdyscyplinarnych Uniwersytetu Jagiellońskiego

  41. Specific immune signatures of T cells as biomarkers of the post-COVID Syndrome and predictors of long-term health dysfun...

    Call: PRELUDIUM BIS 4 , Panel: NZ6

    Principal investigator: dr hab. Katarzyna Piwocka

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  42. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

    Call: POLONEZ BIS 3 , Panel: NZ5

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

  43. Computational deciphering of pro-ferroptotic cell death protein machinery as a fundamental step in the search for therap...

    Call: SONATA BIS 12 , Panel: ST4

    Principal investigator: dr hab. Karolina Anna Mikulska-Rumińska

    Uniwersytet Mikołaja Kopernika, Wydział Fizyki, Astronomii i Informatyki Stosowanej

  44. Studies on the post-receptor mechanisms of TSPO in search of a novel therapeutic target of metabolic syndrome

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: dr Łukasz Kurach

    Uniwersytet Medyczny w Lublinie

  45. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

  46. Mechanisms and therapeutic potential of SGLT2/SGLT1 and NHE-1 inhibition in a rat model of heart failure with preserved ...

    Call: OPUS 23 , Panel: NZ5

    Principal investigator: dr hab. Urszula Mackiewicz

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

  47. Chemical and surgical castration of sex offenders - effective punishment, therapeutic measure or dehumanizing torture? A...

    Call: PRELUDIUM 21 , Panel: HS5

    Principal investigator: Katarzyna Teresa Jakubczak-Fopke

    Uniwersytet Gdański, Wydział Prawa i Administracji

  48. Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: Karolina Barbara Przepiórska-Drońska

    Instytut Farmakologii PAN

  49. The evaluation of therapeutic potential of β-caryophyllene in animal schizophrenia model - behavioral and molecular stud...

    Call: PRELUDIUM 21 , Panel: NZ7

    Principal investigator: dr Magdalena Białoń

    Instytut Farmakologii PAN

  50. Targeting of metabolic and transcriptomic cross-talk between leukemic cells and macrophages as a therapeutic strategy in...

    Call: OPUS 22 , Panel: NZ5

    Principal investigator: dr Baran Natalia

    Instytut Hematologii i Transfuzjologii

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy